Impact Biomedical (IBO) Inventory Average (2025 - 2026)

Impact Biomedical (IBO) posted Inventory Average of $63000.0 for Q1 2026, down 77.01% on a QoQ basis from $274000.0 in Q4 2025.

Impact Biomedical (IBO) Inventory Average (2025 - 2026) Analysis & Trends

Impact Biomedical's Inventory Average history runs 2 years deep, the most recent figure standing at $63000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 644.91 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.15 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Impact Biomedical 47.44 Mn 50.67 Mn - 63,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 63,000.00
Dec 31, 2025 274,000.00
Sep 30, 2025 485,500.00
Jun 30, 2025 487,500.00